MENU
+Compare
ERFSF
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$78.97
Change
+$8.51 (+12.08%)
Capitalization
14.07B

ERFSF Eurofins Scientific Nante Forecast, Technical & Fundamental Analysis

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services... Show more

ERFSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ERFSF with price predictions
Feb 03, 2026

ERFSF's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for ERFSF moved out of overbought territory on January 20, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 75 cases where ERFSF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ERFSF as a result. In of 140 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ERFSF turned negative on January 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 63 similar instances when the indicator turned negative. In of the 63 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ERFSF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ERFSF advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

ERFSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 214 cases where ERFSF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.545) is normal, around the industry mean (12.114). P/E Ratio (29.486) is within average values for comparable stocks, (121.202). Projected Growth (PEG Ratio) (0.803) is also within normal values, averaging (1.874). Dividend Yield (0.009) settles around the average of (0.016) among similar stocks. P/S Ratio (1.791) is also within normal values, averaging (12.571).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ERFSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ERFSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ERFSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

ERFSF paid dividends on July 05, 2021

Eurofins Scientific Nante ERFSF Stock Dividends
А dividend of $0.68 per share was paid with a record date of July 05, 2021, and an ex-dividend date of July 01, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
23 Val Fleuri
Phone
+352 26185321
Employees
62000
Web
https://www.eurofins.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HVAC35.550.70
+2.01%
Advisorshares HVAC And Industrials ETF
VCLN28.900.56
+1.99%
Virtus Duff & Phelps Clean Energy ETF
NVBW34.04-0.17
-0.50%
AllianzIM US Equity Buffer20 Nov ETF
SIXO35.00-0.22
-0.62%
AllianzIM US Equity 6M Bfr10 Apr/Oct ETF
FHLC73.89-0.69
-0.93%
Fidelity MSCI Health Care ETF

ERFSF and Stocks

Correlation & Price change

A.I.dvisor tells us that ERFSF and RGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERFSF and RGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERFSF
1D Price
Change %
ERFSF100%
-1.97%
RGEN - ERFSF
26%
Poorly correlated
-0.59%
KIDS - ERFSF
22%
Poorly correlated
-1.85%
SAUHY - ERFSF
22%
Poorly correlated
-2.68%
BFLY - ERFSF
22%
Poorly correlated
+2.88%
SOAGY - ERFSF
22%
Poorly correlated
+7.02%
More